Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (5)
  • 2024 (4)
  • 2023 (1)
  • 2022 (7)
  • 2021 (5)
  • 2020 (1)
  • 2017 (1)
  • 2016 (1)

Subject

  • Drug Trafficking (29)
  • Take Back Day (26)
  • Outreach/Drug Prevention (22)
  • Prescription Drugs (21)
  • Synthetic drugs (14)
  • Congressional Affairs (12)
  • Fake Pills (11)
  • Press Conferences (11)
  • Major Law Enforcement Operation (10)
  • Arrests/Convictions - Major (9)
  • Fentanyl Awareness (9)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • Red Ribbon (9)
  • Guns/Weapons (8)
  • Prevention/Education - DEA websites GSAD, JTT etc (8)
  • Money Laundering (6)
  • One Pill Can Kill (6)
  • OCDETF/Task Force (5)
  • Seizures (Drugs/Property) (5)
  • Extraditions (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Overdose (4)
  • Critical Incident (3)
  • Gangs (3)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Fentanyl Free America (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Diversion Division (8)

Drug Name

  • Fentanyl (6)
  • Methamphetamine (4)
  • Synthetic Opioids (2)
  • Cocaine (1)
  • Heroin (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Opioids (1)
  • Oxycodone (1)

Field Division

  • Washington, DC (42)
  • New England (33)
  • New York (26)
  • Seattle (22)
  • Chicago (18)
  • New Jersey (17)
  • Houston (15)
  • Atlanta (13)
  • New Orleans (11)
  • El Paso (10)
  • Miami (10)
  • Omaha (8)
  • San Francisco (7)
  • St. Louis (7)
  • Rocky Mountain (6)
  • Dallas (5)
  • Los Angeles (3)
  • Phoenix (3)
  • San Diego (3)
  • Detroit (2)
  • Louisville (2)
  • Caribe (1)
  • Philadelphia (1)
  • Sede (25)
Clear All Results
PRESS RELEASE

FAST KCO Memorial Unveiled In Honor of Fallen DEA Special Agents and Military Personnel Ahead of 24th Anniversary of September 11

Septiembre 05, 2025
WASHINGTON – On September 4, 2025, the U.S. Drug Enforcement Administration unveiled and dedicated a new memorial in honor of 10 Foreign-deployed Advisory and Support Team (FAST) members – three DEA Special Agents and seven U.S. military personnel – whose lives were lost in a helicopter crash in western Afghanistan...
Septiembre 05, 2025
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

Mayo 15, 2025
WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
Mayo 15, 2025
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

Mayo 08, 2025
WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
Mayo 08, 2025
PRESS RELEASE

DEA Seizes Record-Breaking 2.7 Million Fentanyl Pills

Mayo 06, 2025
U.S. Attorney General Pam Bondi joined DEA Leadership, and the men and women of the DEA El Paso Field Division, on Tuesday, May 6, 2025 to announce the single largest seizure of fentanyl pills in DEA history. During an enforcement operation the last week of April, agents from the DEA...
Mayo 06, 2025
PRESS RELEASE

Career Special Agent Derek S. Maltz Appointed to Lead U.S. Drug Enforcement Administration

Enero 21, 2025
WASHINGTON – The Trump Administration has announced the appointment of Derek S. Maltz as Acting Administrator of the U.S. Drug Enforcement Administration. Maltz replaces Anne Milgram who departed the agency last week. Maltz is a passionate, dedicated, career special agent who served 28 years at DEA before retiring in 2014...
Enero 21, 2025
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

Febrero 26, 2024
WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
Febrero 26, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

DEA Encourages Communities to Make Every Day Take Back Day

Enero 24, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has launched a new campaign encouraging the public to make Every Day Take Back Day by utilizing year-round collection sites to dispose of unneeded and unwanted medications. For more than a decade, DEA has worked with state and local law enforcement partners to...
Enero 24, 2024
PRESS RELEASE

Year in Review: DEA Innovates to Fight Fentanyl

Enero 17, 2024
WASHINGTON – In 2023, the U.S. Drug Enforcement Administration marked its 50th anniversary as the only federal agency dedicated to fighting deadly drugs and drug-related violence. This milestone celebrated a half century of dedication to fighting drug trafficking in the United States and around the world, which threatens the public...
Enero 17, 2024
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

Agosto 07, 2023
WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
Agosto 07, 2023
Showing 1 - 10 of 25 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster